Literature DB >> 6357489

Bone marrow transplantation--an expanding approach to treatment of many diseases.

R A Good, N Kapoor, Y Reisner.   

Abstract

Thus, we can conclude that marrow transplantation has already influenced medical practice greatly. It has offered a treatment which often cures patients of more than 20 otherwise lethal diseases. The treatment so horrendously difficult and dangerous at first has already been greatly improved, simplified, and made much safer. The availability of a suitable donor has been much extended and real progress has been made in prevention and perhaps even in treatment of graft-versus-host disease. This has made possible the option of marrow transplantation for every patient in whom we think the treatment may be beneficial. The problem underlying many cases of interstitial pneumonia has been identified and patients are already benefitting clinically from this progress. Progress has also been made which promises antiviral therapy which could reduce, prevent, and ultimately eliminate the intercurrent virus infections which limit the applicability of marrow transplantation, especially for children with severe immunodeficiencies. I do not know how far this line of investigation can be taken. However, just as we have learned stepwise to use marrow transplants from matched siblings to treat many diseases, to use fetal liver in place of bone marrow, to employ matched relative donors when a matched sibling is not available, and, finally, even to use parental donors to achieve correction of SCID, we now have good reason to believe that, ultimately, we can use marrow transplantation without fear of GVHD to address many additional genetically determined and acquired diseases; certainly, for those diseases that involve any of the cells that are derived from bone marrow cells, and perhaps for those attributable even to cells of other organs and tissues, the functions of which are, in whole or in part, a consequence of interactions of marrow-derived cells and cells of ectodermal or endodermal origin, marrow transplantation may be useful. To us, the future of marrow transplantation as a major modality of treatment or prevention of many diseases, including hemoglobinopathesis, immunodeficiencies, hematologic abnormalities, abnormalities of function of marrow-derived cells, and even inborn errors of function of cells of organs and tissues not of marrow origin, seems bright, indeed. Further, with the capacity to introduce resistance genes against viruses and malignancies, autoimmune diseases, and diseases dependent on anomalies of immune response genes, marrow transplantation for many other diseases seems a more remote possibility.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357489     DOI: 10.1016/0008-8749(83)90139-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.

Authors:  N Fukushi; H Arase; B Wang; K Ogasawara; T Gotohda; R A Good; K Onoé
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation.

Authors:  B Y Wang; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Successful pancreatic allografts in combination with bone marrow transplantation in mice.

Authors:  H Iwai; R Yasumizu; K Sugiura; M Inaba; T Kumazawa; R A Good; S Ikehara
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

5.  Varicella pneumonia in a bone marrow-transplanted, immune-reconstituted adenosine deaminase-deficient patient with severe combined immunodeficiency disease.

Authors:  M Ballow; R Hirschhorn
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

6.  Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.

Authors:  B Wang; Y Yamamoto; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Successful liver allografts in mice by combination with allogeneic bone marrow transplantation.

Authors:  T Nakamura; R A Good; R Yasumizu; S Inoue; M M Oo; Y Hamashima; S Ikehara
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice.

Authors:  H Iwai; N K Day; N Hamada; M M Inaba; S Ikehara; R A Good
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Influence of dimethyl myleran on tolerance induction and immune function in major histocompatibility complex-haploidentical murine bone-marrow transplantation.

Authors:  E Ishii; N Gengozian; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Elimination or rescue of cells in culture by specifically targeted liposomes containing methotrexate or formyl-tetrahydrofolate.

Authors:  P Machy; L D Leserman
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.